Adrienne C. Lahti, M.D.
University of Alabama at Birmingham
H-index: 53
North America-United States
Top articles of Adrienne C. Lahti, M.D.
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Topological Perturbations in the Functional Connectome Support the Deficit/Non-deficit Distinction in Antipsychotic Medication-Naïve First Episode Psychosis Patients | Schizophrenia Bulletin | Matheus Teles Jose Omar Maximo Adrienne Carol Lahti Nina Vanessa Kraguljac | 2024/4/26 |
Higher-order functional brain networks and anterior cingulate glutamate+ glutamine (Glx) in antipsychotic-naïve first episode psychosis patients | Translational Psychiatry | Jose O Maximo Frederic Briend William P Armstrong Nina V Kraguljac Adrienne C Lahti | 2024/4/10 |
Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions | Aristotle N Voineskos Colin Hawco Nicholas H Neufeld Jessica A Turner Stephanie H Ameis | 2024/2 | |
Higher-Order Intrinsic Brain Network Trajectories after Antipsychotic Treatment in Medication-Naïve First Episode Psychosis Patients | Biological Psychiatry | Jose O Maximo William P Armstrong Nina V Kraguljac Adrienne C Lahti | 2024/1/24 |
525. Normative Modeling-Derived Deviations in Cortical Thickness are Associated With Cognitive Test Performance in Antipsychotic Naïve First-Episode Psychosis Patients | Biological Psychiatry | Natalie Remiszewski Eric Nelson Andre Marquand Adrienne Lahti Nina Kraguljac | 2023/5/1 |
333. A Longitudinal Assessment of Gamma-Aminobutyric Acid in the Anterior Cingulate Cortex of Antipsychotic Medication-Naïve First Episode Psychosis Patients | Biological Psychiatry | Genelle Samson Jose Maximo Eric Nelson Seyedeh Adnani Adil Bashir | 2023/5/1 |
164. Early Trajectories of Neural Metabolites Following Antipsychotic Treatment in Antipsychotic-Naïve First Episode Psychosis Patients | Biological Psychiatry | Jose Maximo Eric Nelson William Armstrong Nina Kraguljac Adrienne Lahti | 2023/5/1 |
294. Cortical Myelin Mapping in Antipsychotic Medication-Naïve First-Episode Psychosis Patients Who Do or Do Not Display Clinical Features of the Deficit Syndrome | Biological Psychiatry | Victoria King Adrienne Lahti Gerhard Hellemann Matthew Defenderfer Nina Kraguljac | 2023/5/1 |
Hippocampal hyperconnectivity to the visual cortex predicts treatment response | Schizophrenia Bulletin | Eric A Nelson Nina V Kraguljac Jose O Maximo William Armstrong Adrienne C Lahti | 2023/5/1 |
405. Stratifying Duration of Untreated Psychosis (DUP) and Functional Connectivity in Antipsychotic-Naïve First Episode Psychosis Patients | Biological Psychiatry | Hillary Patton Jose Maximo Nina Kraguljac Adrienne Lahti | 2023/5/1 |
533. Does Neurobiological Heterogeneity Pairs Clinical Heterogeneity in Antipsychotic Medication-Naïve First Episode Psychosis Patients Who Do Not Present Features of the … | Biological Psychiatry | Matheus Teles Victoria King Natalie Remiszewski Eric Nelson Adrienne Lahti | 2023/5/1 |
455. A Prospective Study of Hippocampal Subfield Volumes and Glutamate Levels in Medication Naïve First Episode Psychosis Patients | Biological Psychiatry | Eric Nelson Nina Kraguljac Jose Maximo William Armstrong Adrienne Lahti | 2023/5/1 |
The neural substrates of neurological soft signs in schizophrenia: a systematic review | Genelle D Samson Adrienne C Lahti Nina V Kraguljac | 2022/4/26 | |
Contrasting frontoparietal network connectivity in antipsychotic medication-naive first-episode psychosis patients who do and do not display features of the deficit syndrome | Schizophrenia Bulletin | Victoria L King Adrienne C Lahti Jose O Maximo Lawrence W Ver Hoef Sooraj John | 2022/11/1 |
Hippocampal dysconnectivity and altered glutamatergic modulation of the default mode network: a combined resting-state connectivity and magnetic resonance spectroscopy study in … | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging | Eric A Nelson Nina V Kraguljac Jose O Maximo Frederic Briend William Armstrong | 2022/1/1 |
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders–A systematic review of magnetic resonance spectroscopy studies | Mounica Reddy-Thootkur Nina Vanessa Kraguljac Adrienne Carol Lahti | 2022/11/1 | |
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia | Schizophrenia research | Rosalinda C Roberts Lesley A McCollum Kirsten E Schoonover Samuel J Mabry Joy K Roche | 2022/11/1 |
In vivo experience with NRT to increase adherence and smoking abstinence among individuals in the criminal legal system: study protocol for a randomized clinical trial | Frontiers in Psychiatry | Elizabeth S Hawes Sofía Mildrum Chana Alexandra Faust Julianne C Baker Peter S Hendricks | 2022/6/21 |
Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia | Brain and Behavior | Eric A Nelson Nina V Kraguljac Jose O Maximo William Armstrong Adrienne C Lahti | 2022/11 |
Add-on memantine to dopamine antagonism to improve negative symptoms at first psychosis-the AMEND trial protocol | Frontiers in Psychiatry | Katharina O Sandström Olga B Baltzersen Anouk Marsman Cecilie K Lemvigh Vincent O Boer | 2022/5/20 |
